Literature DB >> 8566846

Caffeine phenotyping in patients with familial adenomatous polyposis may shed light on sporadic colon cancer and acetylator status.

M R Welfare, M F Bassendine, M R Welfare, A K Daly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8566846      PMCID： PMC1382996          DOI： 10.1136/gut.38.1.153

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls.

Authors:  D K Scates; A D Spigelman; K P Nugent; R K Phillips; S Venitt
Journal:  Carcinogenesis       Date:  1993-06       Impact factor: 4.944

2.  N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans.

Authors:  D Hickman; E Sim
Journal:  Biochem Pharmacol       Date:  1991-08-08       Impact factor: 5.858

3.  Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas.

Authors:  Y Oda; M Tanaka; I Nakanishi
Journal:  Carcinogenesis       Date:  1994-07       Impact factor: 4.944

4.  Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer.

Authors:  K Shibuta; T Nakashima; M Abe; M Mashimo; M Mori; H Ueo; T Akiyoshi; K Sugimachi; T Suzuki
Journal:  Cancer       Date:  1994-12-15       Impact factor: 6.860

5.  Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer.

Authors:  R Caspari; W Friedl; M Mandl; G Möslein; M Kadmon; M Knapp; K H Jacobasch; K W Ecker; D Kreissler-Haag; G Timmermanns
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321

6.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.

Authors:  F F Kadlubar; M A Butler; K R Kaderlik; H C Chou; N P Lang
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.